Inhibition of histone deacetylase activity by trichostatin A modulates gene expression during mouse embryogenesis without apparent toxicity - PubMed (original) (raw)
. 2001 Feb 15;61(4):1247-9.
Affiliations
- PMID: 11245412
Inhibition of histone deacetylase activity by trichostatin A modulates gene expression during mouse embryogenesis without apparent toxicity
C Nervi et al. Cancer Res. 2001.
Abstract
Remodeling of the chromatin template by inhibition of histone deacetylase (HDAC) activities represents a major goal for transcriptional therapy in neoplastic diseases. Recently, a number of specific and potent HDAC-inhibitors that modulate in vitro cell growth and differentiation have been developed. In this study we analyzed the effect of trichostatin A (TSA), a specific and potent HDAC-inhibitor, on mouse embryos developing in vivo. When administered i.p. to pregnant mice (at a concentration of 0.5-1 mg/kg) at postimplantation stages (embryonic day 8 to embryonic day 10), TSA was not toxic for the mother and did not cause any obvious malformation during somitogenesis or at later stages of development. Treated embryos were born at similar frequency and were indistinguishable from control animals, developed normally, and were fertile. Interestingly, embryos from TSA-treated mice killed during somitogenesis were modestly but consistently larger than control embryos and presented an increased (+2 to +6) number of somites. This correlated with an increased acetylation of histone H4, the number of somites expressing the myogenic factor Myf-5, and the expression of Notch, RARalpha2, and RARbeta2 mRNAs. These data indicate that the effects of TSA on transcription: (a) are not toxic for the mother; (b) transiently accelerated growth in mouse embryos without perturbing embryogenesis; and (c) do not result in teratogenesis, at least in rodents. Thus, TSA might represent a nontoxic and effective agent for the transcriptional therapy of neoplasia.
Similar articles
- Inhibition of histone deacetylase activity on specific embryonic tissues as a new mechanism for teratogenicity.
Menegola E, Di Renzo F, Broccia ML, Prudenziati M, Minucci S, Massa V, Giavini E. Menegola E, et al. Birth Defects Res B Dev Reprod Toxicol. 2005 Oct;74(5):392-8. doi: 10.1002/bdrb.20053. Birth Defects Res B Dev Reprod Toxicol. 2005. PMID: 16193500 - Histone deacetylase inhibitor, trichostatin A, affects gene expression patterns during morphogenesis of chicken limb buds in vivo.
Zhao W, Dai F, Bonafede A, Schafer S, Jung M, Yusuf F, Gamel AJ, Wang J, Brand-Saberi B. Zhao W, et al. Cells Tissues Organs. 2009;190(3):121-34. doi: 10.1159/000193397. Epub 2009 Jan 16. Cells Tissues Organs. 2009. PMID: 19147985 - Effects of histone deacetylation inhibition on neuronal differentiation of embryonic mouse neural stem cells.
Balasubramaniyan V, Boddeke E, Bakels R, Küst B, Kooistra S, Veneman A, Copray S. Balasubramaniyan V, et al. Neuroscience. 2006 Dec 28;143(4):939-51. doi: 10.1016/j.neuroscience.2006.08.082. Epub 2006 Nov 3. Neuroscience. 2006. PMID: 17084985 - Inhibition of MMTV transcription by HDAC inhibitors occurs independent of changes in chromatin remodeling and increased histone acetylation.
Mulholland NM, Soeth E, Smith CL. Mulholland NM, et al. Oncogene. 2003 Jul 31;22(31):4807-18. doi: 10.1038/sj.onc.1206722. Oncogene. 2003. PMID: 12894222
Cited by
- HDAC inhibitors in kidney development and disease.
Brilli LL, Swanhart LM, de Caestecker MP, Hukriede NA. Brilli LL, et al. Pediatr Nephrol. 2013 Oct;28(10):1909-21. doi: 10.1007/s00467-012-2320-8. Epub 2012 Oct 7. Pediatr Nephrol. 2013. PMID: 23052657 Free PMC article. Review. - Histone deacetylase inhibition activates transcription factor Nrf2 and protects against cerebral ischemic damage.
Wang B, Zhu X, Kim Y, Li J, Huang S, Saleem S, Li RC, Xu Y, Dore S, Cao W. Wang B, et al. Free Radic Biol Med. 2012 Mar 1;52(5):928-36. doi: 10.1016/j.freeradbiomed.2011.12.006. Epub 2011 Dec 17. Free Radic Biol Med. 2012. PMID: 22226832 Free PMC article. - Histone Deacetylase Inhibitors: Providing New Insights and Therapeutic Avenues for Unlocking Human Birth.
Ilicic M, Zakar T, Gregson A, Hussein WM, Smith R, Paul JW. Ilicic M, et al. Reprod Sci. 2022 Nov;29(11):3134-3146. doi: 10.1007/s43032-021-00778-x. Epub 2021 Oct 28. Reprod Sci. 2022. PMID: 34713433 Review. - Regulation of histone acetylation and apoptosis by trichostatin in HL-60 cells.
Li X, Chen W, Gu J, Cui G, Chen Y. Li X, et al. J Huazhong Univ Sci Technolog Med Sci. 2004;24(6):572-4. doi: 10.1007/BF02911358. J Huazhong Univ Sci Technolog Med Sci. 2004. PMID: 15791844 - Histone deacetylases control neurogenesis in embryonic brain by inhibition of BMP2/4 signaling.
Shakèd M, Weissmüller K, Svoboda H, Hortschansky P, Nishino N, Wölfl S, Tucker KL. Shakèd M, et al. PLoS One. 2008 Jul 16;3(7):e2668. doi: 10.1371/journal.pone.0002668. PLoS One. 2008. PMID: 18628975 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Molecular Biology Databases
Research Materials